MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Scleroderma and Systemic Sclerosis in Canada
LA JOLLA, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
The third Hong Kong Shopping Festival extends into ASEAN for the first time
Focus Graphite Achieves up to 98.7% Carbon Concentrate Through Mechanical Processing and Activates Downstream Qualification Platform
DD.NYC Launches Full-Service Video Production Division
Launchit Solutions and Privacy Horizon Partner to Help Canadian Health Tech Companies Build, Govern, and Scale with Confidence
DesignRush Podcast, Carla Johnson Examines Why Innovation Claims Fail With Buyers